(MENAFN - GlobeNewsWire - Nasdaq) NOVATO, Calif., April 19, 2024 (GLOBE NEWSWIRE) Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and . .
Wedbush Reaffirms Neutral Rating for Ultragenyx Pharmaceutical (NASDAQ:RARE) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
NOVATO, Calif., April 19, 2024 Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases,.